This is a historical report — it no longer reflects this drug's current status. Current status: Permanently Discontinued. View this drug's full profile page →
CLINDAMYCIN INJECTION USP
SANDOZ CANADA INCORPORATED
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is CLINDAMYCIN INJECTION USP discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that CLINDAMYCIN INJECTION USP 150MG has been permanently discontinued (last updated October 18, 2017). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is CLINDAMYCIN INJECTION USP not available?
The reason the manufacturer reported: Business reasons.
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
02230535
Strength
150MG
Dosage Form
SOLUTION
Route
INTRAVENOUS
Active Ingredient
CLINDAMYCIN
Tier
Unrated
Last Updated
2024-08-23
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
CLINDAMYCIN INJECTION USP has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from SANDOZ CANADA INCORPORATED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
200MG · DIN 02243098
5MG · DIN 02269198
500MCG · DIN 02248181
250MG · DIN 02242971
50MG · DIN 02242325
DIN 02495929
DIN 02495910
DIN 02495937
250MG · DIN 02246533
1MG · DIN 02548968
10MG · DIN 02513420
10MG · DIN 02236759